Completing data — refresh the page later to see the latest
175033-36-0CC(=O)Oc1ccccc1C(=O)Oc1cccc(CO[N+](=O)[O-])c1IOJUJUOXKXMJNF-UHFFFAOYSA-N175033-36-0DTXSID60938618CHEMBL374385CHEBI:125482Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesNitroaspirin (NCX 4016) is a nitric oxide (NO) donor and a nitro-derivative of Aspirin, which combines with Nitroaspirin to inhibit cyclooxygenase. Nitroaspirin (NCX 4016) has antithrombotic and anti-platelet properties and acts as a direct and irreversible inhibitor of COX-1. Nitroaspirin (NCX 4016) causes significant induction of cell cycle arrest and apoptosis in Cisplatin-resistant human ovarian cancer cells via down-regulation of EGFR/PI3K/STAT3 signaling and modulation of Bcl-2 family proteins[1][2][3][4].
No reaction records under the current filter.
Loading…
DefinitionChEBI: 2-acetyloxybenzoic acid [3-(nitrooxymethyl)phenyl] ester is a carbonyl compound.